The demand for glucagon-like peptide 1 (GLP-1s) receptor agonists for overweight/obesity has created a clinical conundrum for ...
A higher BMI is consistently associated with longer operative times and increased complications across a wide range of ...
Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback